Nasdaq 100 Leaders: DexCom Surges 3.6%, Alnylam Pharmaceuticals Drops 8.1%

lunes, 12 de enero de 2026, 11:02 am ET1 min de lectura
ALNY--
DXCM--

In early trading, DexCom rose 3.6% to lead the Nasdaq 100 index, while Alnylam Pharmaceuticals fell 8.1% to be the worst performer. Other notable movers include Insmed, down 3.7%, and Palantir Technologies, up 1.9%.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios